I would like to ask a favor of anyone planning to attend the March 21st workshop regarding FDA oversight of PET radiopharmaceuticals: A synopsis of the meeting would be greatly appreciated. Several members from our PET Dept. will be attending, but I would like to get an HP's perspective on the issues. Thank you in advance.